a<p>Mice were vaccinated with 10<sup>7</sup> PFUs or 10<sup>3</sup> PFUs of C-S8p260, indicated for each group.</p>b<p>Neutralization titers are expressed as PRN70 (plaque-reduction neutralization titer 70): the reciprocal of the dilution of serum that causes neutralization of 70% of PFU.</p>c<p>30 days post-immunization.</p>d<p>3 days post-challenge with 10<sup>4</sup> PFUs of C-S8c1.</p
*<p>Reciprocal titer of serum capable of neutralizing <sup>a</sup> 80% or <sup>b</sup> 50% of TC-83 ...
<p>Mean titers ±SD are shown. Asterisks (*) indicate that the values of pRC/CMV-VP1- and LASW1-treat...
1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
a<p>VNT, virus neutralization titer (log<sub>10</sub> of the reciprocal of the last dilution able to...
<p>Virus-neutralizing antibody activities in sera collected 2 weeks after immunization. Dilutions of...
<p>(A) Sera collected at 10 days post-last vaccination were tested for neutralization of MERS-CoV in...
<p>Seven-week-old BALB/c mice were individually primed and boosted at 14-day intervals i.p., s.c., o...
<p>Serum was isolated from the peripheral blood of F-MLV–infected <i>Myd88</i><sup>−/−</sup> and <i>...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>Sera were collected from mice on days 0, 14, 28, 42, and 56. 25 µl of serial two-fold dilutions o...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>Serum from infected wild-type (WT) or TLR7-deficient mice (<i>Tlr7</i> KO) (<b>A</b>), as well as...
*<p>Reciprocal titer of serum capable of neutralizing <sup>a</sup>80% or <sup>b</sup>50% of TC-83 pl...
*<p>Reciprocal titer of serum capable of neutralizing <sup>a</sup> 80% or <sup>b</sup> 50% of TC-83 ...
<p>Mean titers ±SD are shown. Asterisks (*) indicate that the values of pRC/CMV-VP1- and LASW1-treat...
1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
a<p>VNT, virus neutralization titer (log<sub>10</sub> of the reciprocal of the last dilution able to...
<p>Virus-neutralizing antibody activities in sera collected 2 weeks after immunization. Dilutions of...
<p>(A) Sera collected at 10 days post-last vaccination were tested for neutralization of MERS-CoV in...
<p>Seven-week-old BALB/c mice were individually primed and boosted at 14-day intervals i.p., s.c., o...
<p>Serum was isolated from the peripheral blood of F-MLV–infected <i>Myd88</i><sup>−/−</sup> and <i>...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>Sera were collected from mice on days 0, 14, 28, 42, and 56. 25 µl of serial two-fold dilutions o...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
1<p>Mice were immunized with D1ED III (10 µg/dose) formulated with the indicated adjuvants three tim...
<p>Serum from infected wild-type (WT) or TLR7-deficient mice (<i>Tlr7</i> KO) (<b>A</b>), as well as...
*<p>Reciprocal titer of serum capable of neutralizing <sup>a</sup>80% or <sup>b</sup>50% of TC-83 pl...
*<p>Reciprocal titer of serum capable of neutralizing <sup>a</sup> 80% or <sup>b</sup> 50% of TC-83 ...
<p>Mean titers ±SD are shown. Asterisks (*) indicate that the values of pRC/CMV-VP1- and LASW1-treat...
1<p>Groups of BALB/c mice (n = 5) were immunized three times subcutaneously with 3, 10, or 30 µg of ...